Cambridge Newswire

Comprehensive Real-Time News Feed for Cambridge, MA.

Results 1 - 20 of 68 for "u:bloomberg.com" in Cambridge, MA

  1. Trump Visa Crackdown Threatens BiotechRead the original story w/Photo

    16 hrs ago | Bloomberg

    From tiny startups to global giants, the companies that sustain the $324 billion U.S. biotech industry are increasingly alarmed as President Donald Trump considers following his controversial travel ban with restrictions on skilled foreign immigrants. Bloomberg's Doni Bloomfield reports from the nation's biotech hub in Cambridge, Massachusetts.

    Comment?

  2. 12.2 Million People Have Signed Up for Obamacare This YearRead the original story w/Photo

    Friday Feb 10 | Bloomberg

    More than 12.2 million people have signed up for coverage nationwide this year under the Obama-era health care law even with the uncertainty created by President Donald Trump's vow to repeal and replace it. A count by The Associated Press shows that many consumers returned to the program despite its problems.

    Comment?

  3. Engineering Software Finally Starts Moving to the Cloud an hour agoRead the original story w/Photo

    Thursday Feb 9 | Bloomberg

    At Onshape, Fridays are for show and tell. Engineers at the computer-aided design startup gather in the break room at its offices in Cambridge, Mass., to show off improvements in their cloud software to a chorus of oohs and aahs.

    Comment?

  4. Biogen Profit Beats Estimates as New CEO Takes the HelmRead the original story

    Thursday Jan 26 | The Washington Post

    Biogen Inc. posted fourth-quarter profit that beat analysts' estimates after cutting expenses as sales growth of its top multiple sclerosis drug stalled, the last set of results before new Chief Executive Officer Michel Vounatsos took the helm of the biotechnology company. Earnings were $5.04 a share last quarter, excluding some items, the company said in a statement Thursday, compared with the $4.96 average projection.

    Comment?

  5. Secretive Biotech Unicorn Moderna Unveils Pipeline, FinancialsRead the original story

    Jan 9, 2017 | The Washington Post

    Moderna Therapeutics Inc., one of the best-funded private biotechnology companies in the U.S., unveiled its long-secret research and development pipeline on Monday, including experimental vaccines, cancer treatments and a cardiovascular therapy. The Cambridge, Massachusetts-based startup has about $1.3 billion in cash on hand from investors, pharmaceutical partners and government grants, according to a presentation Monday at the J.P.Morgan Chase & Co.

    Comment?

  6. Takeda to Buy Cancer Drug Maker Ariad for $4.66 BillionRead the original story w/Photo

    Jan 9, 2017 | Bloomberg

    Takeda Pharmaceutical Co. will expand its portfolio of cancer drugs and buy Ariad Pharmaceuticals Inc. for about $4.66 billion.

    Comment?

  7. Harvard Endowment's New Boss Delays Gala to Review Fund Strategy an hour agoRead the original story w/Photo

    Dec 22, 2016 | Bloomberg

    Harvard Management Co. , which oversees a $35.7 billion endowment that's been plagued by underperformance, is postponing next month's Winter Gala as its new chief executive officer leads a review of the fund's strategy and structure.

    Comment?

  8. Virginia Cracks the Code on Voter ID LawsRead the original story w/Photo

    Dec 15, 2016 | The Washington Post

    Noah Feldman is a Bloomberg View columnist. He is a professor of constitutional and international law at Harvard University and was a clerk to U.S. Supreme Court Justice David Souter.

    Comment?

  9. Smaller, Safer, Saltier: Next-Gen Nuclear Draws Thiel and UNRead the original story

    Dec 7, 2016 | The Washington Post

    A new breed of nuclear reactor designed by engineers from the millennial generation has gained the support of both billionaires and the United Nations agency overseeing the industry. The International Atomic Energy Agency is opening an exchange for countries to trade information on a technology that uses molten salt to moderate the atomic reaction of liquid fuels, rather than water and solid fuel.

    Comment?

  10. Your Evening Briefing 2 hours agoRead the original story w/Photo

    Dec 2, 2016 | Bloomberg

    Trump Campaign Manager Kellyanne Conway and Clinton Campaign Manager Robby Mook speak during the event titled "War Stories: Inside Campaign 2016" at the Harvard Institute of Politics Forum on December 1, 2016 in Cambridge, Massachusetts. Who's who in the battle for Trump's team .  As Donald Trump taps billionaires and GOP insiders for his Cabinet, with his latest pick  being retired General James Mattis for defense secretary, here are the Bloomberg stories that tell the tale of the most unlikely presidential election in U.S. history.

    Comment?

  11. Trump and Clinton Campaign Aides Clash at Harvard ForumRead the original story w/Photo

    Dec 2, 2016 | Bloomberg

    Trump Campaign Manager Kellyanne Conway and Clinton Campaign Manager Robby Mook speak during the event titled 'War Stories: Inside Campaign 2016' at the Harvard Institute of Politics Forum on December 1, 2016 in Cambridge, Massachusetts. Hillary Clinton's senior campaign strategist did not mince his words Thursday when confronted by top staffers of President-elect Donald Trump: he doesn't have a voter mandate.

    Comment?

  12. Hillary Clinton to Supporters: Keep Fighting Because 'America Is Worth It'Read the original story w/Photo

    Nov 17, 2016 | Bloomberg

    Wednesday's speech to the Children's Defense Fund marked the first time since her concession that Clinton publicly talked about her election defeat. Former Secretary of State Hillary Clinton delivers remarks while being honored during the Children's Defense Fund's Beat the Odds Celebration at the Newseum November 16, 2016 in Washington, DC.

    Comment?

  13. Nestle Pays $145 Million for Stake in Biotech Firm AimmuneRead the original story

    Nov 6, 2016 | The Washington Post

    Nestle SA's health unit is investing $145 million for a 15 percent stake in Aimmune Therapeutics Inc., a California maker of food-allergy therapies. Nestle Health Science, a subsidiary of the Swiss food giant, will pay $19.20 a share for about 7.55 million newly issued shares of Aimmune, and the unit's Chief Executive Officer Greg Behar will join the biotech firm's board of directors, Aimmune said Friday in a statement.

    Comment?

  14. Nestle Pays $145 Million for Stake in Biotech Firm AimmuneRead the original story

    Nov 6, 2016 | The Washington Post

    Nestle SA's health unit is investing $145 million for a 15 percent stake in Aimmune Therapeutics Inc., a California maker of food-allergy therapies. Nestle Health Science, a subsidiary of the Swiss food giant, will pay $19.20 a share for about 7.55 million newly issued shares of Aimmune, and the unit's Chief Executive Officer Greg Behar will join the biotech firm's board of directors, Aimmune said Friday in a statement.

    Comment?

  15. Harvard Raises $1.2 Billion But Slow Returns Crimp BudgetRead the original story

    Nov 2, 2016 | The Washington Post

    Harvard University raised a record $1.2 billion in annual donations yet warned it faces a tight budget because of its underperforming endowment, which has faced internal criticism over its management. The fundraising total, the second-largest ever in higher education and the biggest for Harvard, demonstrates the concentration of wealth at American colleges.

    Comment?

  16. Harvard Raises Record $1.2 Billion But Slow Returns Crimp BudgetRead the original story

    Nov 1, 2016 | The Washington Post

    Harvard University raised a record $1.2 billion in annual donations yet warned it faces a tight budget because of its underperforming endowment, which has faced internal criticism over its management. The fundraising total, the second-largest ever in higher education and the biggest for Harvard, demonstrates the concentration of wealth at American colleges.

    Comment?

  17. Nobel Laureate Merton Says Buffett's Financial WMDs Help SocietyRead the original story

    Oct 27, 2016 | The Washington Post

    When Paul Volcker said the last financial innovation that improved society was the automated teller machine, Robert C. Merton took offense. Now the Nobel Prize-winning professor is hitting back, pointing to markets for options and interest-rate swaps that are humming along as fast as ever.

    Comment?

  18. Nobel Laureate Merton Says Buffett's Financial WMDs Help SocietyRead the original story

    Oct 27, 2016 | The Washington Post

    When Paul Volcker said the last financial innovation that improved society was the automated teller machine, Robert C. Merton took offense. Now the Nobel Prize-winning professor is hitting back, pointing to markets for options and interest-rate swaps that are humming along as fast as ever.

    Comment?

  19. Harvard Called - Lazy, Fat, Stupid' in Endowment Report Last Year 18 minutes agoRead the original story

    Oct 27, 2016 | Bloomberg

    Harvard University's money managers collected tens of millions in bonuses by exceeding "easy-to-beat" investment goals even as the college's endowment languished, employees complained in an internal review. The consulting firm McKinsey & Co., in a wide-ranging examination, zeroed in on the endowment's benchmarks, or investment targets.

    Comment?

  20. Tudor Said to Invest Millions in Bid to Blend Data and MacroRead the original story

    Oct 23, 2016 | The Washington Post

    Paul Tudor Jones built his career on market savvy and a strong stomach for risk. Now, his gut is telling him to bet that data and the smarts of scientists can help his $10.6 billion hedge fund firm find profitable investment ideas.

    Comment?

Cambridge Job Listings
View or post Cambridge job listings on Topix.
Cambridge Real Estate
News, listings, and foreclosures in Cambridge from Topix.
Cambridge Mortgages
Find mortgage rates in Cambridge on Topix.